copy and paste from Morgan Stanley:
IBM has been on a nearly unprecedented run in the last 3 months, outperforming the S&P 500 by 20 points since 2Q earnings. IBM is now trading at all-time valuation highs on an absolute and relative basis. This momentum has been driven by 3 prevailing bull theses:
(1) excitement around growth accelerating in CY25 with ELA/Mainframe cycles and the HCP acquisition,
(2) the view that IBM is/will be an AI beneficiary,
and (3) an expectation that RHT will be a beneficiary of volatility at VMW.
IBM has been on a nearly unprecedented run in the last 3 months, outperforming the S&P 500 by 20 points since 2Q earnings. IBM is now trading at all-time valuation highs on an absolute and relative basis. This momentum has been driven by 3 prevailing bull theses:
(1) excitement around growth accelerating in CY25 with ELA/Mainframe cycles and the HCP acquisition,
(2) the view that IBM is/will be an AI beneficiary,
and (3) an expectation that RHT will be a beneficiary of volatility at VMW.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.